Endologix Acquires PQ Bypass to Increase Treatments for Peripheral Arterial Disease.

MANews-(C)2009-2021

California-based vascular disease treatment provider Endologix LLC has acquired US-based medical technology provider PQ Bypass, Inc., offering new treatments for severe peripheral arterial disease in AAA and PAD patients, the company said.

Terms of the transaction were not disclosed.

The acquisition of PQ Bypass builds on Endologix's history in the treatment of abdominal aortic aneurysm to champion disruptive technologies for the treatment of vascular disease.

Endologix...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT